chr1-181483794-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 3P and 5B. PM2PP2BP6BS1
The NM_001205293.3(CACNA1E):c.50G>A(p.Gly17Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,612,330 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000027 ( 0 hom. )
Consequence
CACNA1E
NM_001205293.3 missense
NM_001205293.3 missense
Scores
4
13
2
Clinical Significance
Conservation
PhyloP100: 6.53
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1E. . Gene score misZ 5.8125 (greater than the threshold 3.09). Trascript score misZ 6.7013 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy, developmental and epileptic encephalopathy, 69.
BP6
Variant 1-181483794-G-A is Benign according to our data. Variant chr1-181483794-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1708857.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=1}.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00000274 (4/1460426) while in subpopulation AMR AF= 0.0000895 (4/44714). AF 95% confidence interval is 0.0000298. There are 0 homozygotes in gnomad4_exome. There are 2 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1E | NM_001205293.3 | c.50G>A | p.Gly17Glu | missense_variant | 1/48 | ENST00000367573.7 | NP_001192222.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.50G>A | p.Gly17Glu | missense_variant | 1/48 | 1 | NM_001205293.3 | ENSP00000356545.2 | ||
CACNA1E | ENST00000360108.7 | c.50G>A | p.Gly17Glu | missense_variant | 1/47 | 5 | ENSP00000353222.3 | |||
CACNA1E | ENST00000367570.6 | c.50G>A | p.Gly17Glu | missense_variant | 1/47 | 1 | ENSP00000356542.1 | |||
CACNA1E | ENST00000621791.4 | c.50G>A | p.Gly17Glu | missense_variant | 1/46 | 1 | ENSP00000481619.1 | |||
CACNA1E | ENST00000524607.6 | c.485G>A | p.Gly162Glu | missense_variant | 3/12 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151904Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
151904
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248474Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134894
GnomAD3 exomes
AF:
AC:
4
AN:
248474
Hom.:
AF XY:
AC XY:
3
AN XY:
134894
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460426Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726486
GnomAD4 exome
AF:
AC:
4
AN:
1460426
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
726486
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151904Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74166
GnomAD4 genome
AF:
AC:
1
AN:
151904
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74166
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 07, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 04, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;D;T;.;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.;D;.;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;M;.;M;.;M;M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;.;D;D;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;D;D;.;.;.;.
Sift4G
Uncertain
.;D;D;D;D;D;D;D;D
Polyphen
1.0
.;D;.;.;.;.;D;.;.
Vest4
0.42, 0.45, 0.48, 0.42, 0.49, 0.44, 0.51
MutPred
0.30
.;Loss of catalytic residue at G17 (P = 0.0118);Loss of catalytic residue at G17 (P = 0.0118);Loss of catalytic residue at G17 (P = 0.0118);Loss of catalytic residue at G17 (P = 0.0118);Loss of catalytic residue at G17 (P = 0.0118);Loss of catalytic residue at G17 (P = 0.0118);Loss of catalytic residue at G17 (P = 0.0118);Loss of catalytic residue at G17 (P = 0.0118);
MVP
MPC
2.5
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at